A single arm phase II study of adjuvant anti PD1 (pembrolizumab) in combination with hormonal therapy in patients with hormone receptor (HR) positive localized inflammatory …
CANCER RESEARCH(2018)
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要
CANCER RESEARCH(2018)